dc.contributor.author | CARTWRIGHT, R. | |
dc.contributor.author | GATTORNO, M. | |
dc.contributor.author | SMITH, J. | |
dc.contributor.author | LESLIE, K. S. | |
dc.contributor.author | JIMENEZ, S. | |
dc.contributor.author | MORELL-DUBOIS, S. | |
dc.contributor.author | DAVIS, N. | |
dc.contributor.author | PATEL, N. | |
dc.contributor.author | WIDMER, A. | |
dc.contributor.author | PREISS, R. | |
dc.contributor.author | Lachmann, H. J. | |
dc.contributor.author | Gül, Ahmet | |
dc.contributor.author | KUEMMERLE-DESCHNER, Jasmin B. | |
dc.contributor.author | HACHULLA, E. | |
dc.contributor.author | Hawkins, P. N. | |
dc.contributor.author | TRAN, T. A. | |
dc.contributor.author | Bader-Meunier, B. | |
dc.contributor.author | HOYER, J. | |
dc.date.accessioned | 2021-03-04T18:16:34Z | |
dc.date.available | 2021-03-04T18:16:34Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | KUEMMERLE-DESCHNER J. B. , HACHULLA E., CARTWRIGHT R., Hawkins P. N. , TRAN T. A. , Bader-Meunier B., HOYER J., GATTORNO M., Gül A., SMITH J., et al., "Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes", ANNALS OF THE RHEUMATIC DISEASES, cilt.70, ss.2095-2102, 2011 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_89d2421d-7d65-4de6-882c-b9f2c199ce4e | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/93452 | |
dc.identifier.uri | https://doi.org/10.1136/ard.2011.152728 | |
dc.description.abstract | Objective Longer-term effects of prolonged selective interleukin-1 beta blockade with canakinumab were evaluated in the largest cohort of cryopyrin-associated periodic syndrome (CAPS) patients studied to date. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.title | Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes | |
dc.type | Makale | |
dc.relation.journal | ANNALS OF THE RHEUMATIC DISEASES | |
dc.contributor.department | Eberhard Karls University of Tubingen , , | |
dc.identifier.volume | 70 | |
dc.identifier.issue | 12 | |
dc.identifier.startpage | 2095 | |
dc.identifier.endpage | 2102 | |
dc.contributor.firstauthorID | 50846 | |